Earnings Call · Q4 FY2021·2022-03-30

Q4 21EPS -14.29%·Rev n/aQ3 21EPS +37.50%·Rev n/aQ2 21EPS -100.00%*·Rev n/aQ1 21EPS -100.00%*·Rev n/a⚠ consensus missing

ZEVRA THERAPEUTICS, INC. ZVRA

Jason Rando — Investor Relations

Travis Mickle — Chief Executive Officer

LaDuane Clifton — Chief Financial Officer

−5.5%1d on move date−3.9% vs SPY3d−2.1%5d−4.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ZVRA calls or request research access.

More ZVRA calls Browse calls Request research access